Current Pharmaceutical Design
Title:Current Status and Advances in Severe Drug Hypersensitivity Reactions
Volume: 25 Issue: 36
Author(s): Semanur Kuyucu
Affiliation:
Export Options
About this article
Cite this article as:
Kuyucu Semanur , Current Status and Advances in Severe Drug Hypersensitivity Reactions, Current Pharmaceutical Design 2019; 25 (36) . https://dx.doi.org/10.2174/138161282536191212125232
DOI https://dx.doi.org/10.2174/138161282536191212125232 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
17
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases
Current Pharmaceutical Design Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
Current Medicinal Chemistry Paracrine Mechanisms Involved in Mesenchymal Stem Cell Differentiation into Cardiomyocytes
Current Stem Cell Research & Therapy Liver Tolerance and the Manipulation of Immune Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Pivotal Roles of Interleukin-17 as the Epicenter of Bone Loss Diseases
Current Pharmaceutical Design Kinase Inhibitors with Redox and Anti-inflammatory Activities
Current Topics in Medicinal Chemistry Probiotic Research in Australia, New Zealand and the Asia-Pacific Region
Current Pharmaceutical Design Mesenchymal Stem Cells in Renal Ischemia-Reperfusion Injury: Biological and Therapeutic Perspectives
Current Stem Cell Research & Therapy Exosomes: The Messengers of Health and Disease
Current Neuropharmacology Compositions for Treatment of Cancer and Inflammation
Recent Patents on Anti-Cancer Drug Discovery The Association of Respiratory Viruses with Oxidative Stress and Antioxidants. Implications for the COVID-19 Pandemic
Current Pharmaceutical Design Dietary Fish Oil Reduces Colon Cancer Risk
Current Organic Chemistry The Anandamide Degradation System as Potential Target for the Treatment of Central Nervous System Related Disorders
Current Medicinal Chemistry - Central Nervous System Agents Xenobiotic Acyl Glucuronides and Acyl CoA Thioesters as Protein- Reactive Metabolites With the Potential to Cause Idiosyncratic Drug Reactions
Current Drug Metabolism Biological Effects of Licochalcones
Mini-Reviews in Medicinal Chemistry Herbs for Effective Treatment of Diabetes Mellitus Wounds: Medicinal Chemistry and Future Therapeutic Options
Mini-Reviews in Medicinal Chemistry Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention
Current Cancer Drug Targets B-Cell Based Gene Therapy for Autoimmune Diseases
Infectious Disorders - Drug Targets Cognitive Consequences of a Sustained Monocyte Type 1 IFN Response in HIV-1 Infection
Current HIV Research Base-Modified Nucleosides as Chemotherapeutic Agents: Past and Future
Current Topics in Medicinal Chemistry